After having cut its teeth on the cannabis, food, and COVID-19 testing markets, MATTIO client @PathogenDX is now poised to launch a microarray-based test for urinary tract infections. Via @360DxNews: https://t.co/HXHCsX63Oh

visibility 53
hometechnologymattio

PathogenDx Plans Microarray-Based UTI Test as Focus Remains on Clinical Market

360dx.com
  • Mattio avatar Mattio May 4, 2023
After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is now poised to launch a microarray-based test for urinary tract infections.

Addiction >

Cannabis >

Dispensary >

Health >

Opioids >

Psychedelics >

Science >

Also In Mattio

Also In Technology

After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is now poised to launch a microarray-based test for urinary tract infections.